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ABSTRACT The burgeoning ﬁelds of in vivo three-dimensional (3D) microscopy and endomicroscopy, as well as ex vivo tissue
cytometry have introduced new challenges for tissue preparation and staining with exogenous molecular contrast agents. These
challenges include effective delivery of the agents, and once delivered, distinguishing between bound verses unbound molecular
probes. If applied topically, there are additional issues with rinsing off unbound probe, which can be nonuniform and inefﬁcient in
thick tissues, thus leading to ambiguous contrast and a large nonspeciﬁc background that may obscure molecule-speciﬁc stain-
ing. Therefore, we have developed a ratiometric 3D microscopy scheme that not only reduces the effects of nonspeciﬁc sources
of contrast, but also enables quantiﬁcation of the relative binding afﬁnity of imaging probes to their biomarker targets. Here we
demonstrate this ratiometric approach by simultaneously imaging a HER2/neu (erbB2)-targeted monoclonal antibody labeled
with one ﬂuorophore and an isotype-matched negative control antibody labeled with another ﬂuorophore. By taking a pixel-
by-pixel calibrated ratio between the signals from each ﬂuorescent image channel, accurate quantiﬁcation of speciﬁc versus
nonspeciﬁc binding afﬁnity is achieved with cultured cells, yielding data that are in agreement with analyses via ﬂow cytometry.
We also demonstrate quantitative 3D microscopic imaging of biomarker expression in tissue models and in thick human biopsy
samples of normal, HER2-negative, and HER2-positive breast tumors. This strategy enables rapid, quantitative, and unambig-
uous volumetric microscopy of biomarker expression in thick tissues, including whole biopsies, and will enable real-time optical
assessment of disease markers in the living body.INTRODUCTION
Significant and rapid advances are being made in in vivo
microscopy, as seen for example by the recent development
of endomicroscopes that allow for noninvasive optical
sectioning and real-time microscopic analyses of living
tissues (1–9). These technologies offer the promise of real-
time imaging of glandular and cellular morphology, beneath
the epithelial or mucosal surface, without having to cut the
tissue. Such advances will provide guidance for tissue
sampling, leading to more informed biopsies, and perhaps
the replacement of some biopsies with noninvasive imaging,
or ‘‘optical biopsies’’. Many of these approaches have relied
upon intrinsic contrast between diseased versus normal
tissues. Although useful in some cases, these differences
are often subtle and uninformative. The use of contrast
agents that target specific molecular biomarkers is a hallmark
of immunohistochemistry. If vital immunolabeling can be
made possible in vivo, it would enable earlier disease detec-
tion and more accurate diagnosis and staging of disease.
The use of exogenous contrast agents for three-dimen-
sional (3D) microscopy of fresh intact tissues presents
unique challenges that cannot be addressed by methods for
conventional immunohistochemical analysis. Cellular and
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imen preparation, including tissue fixation, embedding,
physical sectioning, mounting on slides, staining, and rinsing
before molecular interrogation. When using antibodies that
target specific disease markers in conventional immunohisto-
chemistry, elaborate blocking and rinsing protocols have
been developed to minimize background staining and to
reduce erroneous sources of contrast. Such protocols are
not possible in thick or live tissues due to poor access to cells
deep in the tissues, limited ability to wash off unbound
probe, and severe time constraints for the acquisition of
relevant data. Since the application of exogenous contrast
agents, as well as the rinsing away of unbound probe, is
neither efficient nor uniform in fresh intact tissues, a large
nonspecific background often exists, along with nonspecific
sources of contrast that are unrelated to the molecular
target(s) of interest.
Molecularly targeted in vivo microscopy in humans has
recently been demonstrated (8). Confocal endomicroscopic
imaging revealed that a topically applied heptapeptide, conju-
gated to fluorescein dye, demonstrated preferential binding to
areas of dysplasia in the human colon. In a related study, the
same confocal endomicroscope was used to image fluores-
cence contrast from an untargeted sodium fluorescien dye
(9). This second study concluded that morphological or phys-
iological alterations in dysplastic foci leads to enhanced reten-
tion of the untargeted dye as compared to normal colonic
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a diagnostic stain. Since the second study (9) indicated that
the accumulation of contrast agents can be significant owing
to anatomical and physiological changes alone, without
molecular targeting, the first study of specific molecular
binding (8) would have benefited from a technique that could
remove such confounding nonspecific effects. In general,
possible sources of nonspecific contrast include: nonuniform
application and transport kinetics of molecular probes,
nonuniform application and kinetics of the rinsing medium,
poor optical contact between the microscope and tissue, and
the accumulation or pooling of contrast agents due to uneven
tissue geometry or morphology. A method to remove, or
otherwise manage these nonspecific sources of contrast
during real-time 3D microscopy is needed.
With in vivo microscopy, the ability to quantify binding
affinity is particularly important due to the small fields of
view that are imaged. In macroscopic imaging approaches,
one is often able to image both diseased and adjacent normal
tissues within the same field of view, thereby providing
a convenient reference for comparison. Within a microscopic
field of view, however, it is difficult to image the exact tran-
sition between tissue types. This can be addressed by stitch-
ing together many fields of view into a mosaic, but this still
does not provide an absolute measure of binding affinity that
accounts for nonspecific contrast.
Ratiometric imaging has previously been used to improve
the sensitivity and to quantify fluorescence microscopic
detection of Ca2þ-sensitive dyes (10,11), pH-sensitive dyes
(12), and FRET (fluorescence resonance energy transfer)
reporters using bench top microscopes (13,14). In wide-field
fluorescence imaging of an exogenous contrast agent,
a double ratio technique has been developed to eliminate
the effects of autofluorescence and tissue scattering varia-
tions for improved quantification of probe concentration
(15,16). However, the double ratio technique does not distin-
guish between molecularly targeted versus nonspecific probe
accumulation in tissues, which is likely to be a major chal-
lenge for interpretation of images obtained in vivo. Advances
in ratiometric imaging and the application of this method to
miniature clinical microscopes will both improve our ability
to rapidly analyze thick tissues such as intact biopsies
(‘‘tissue cytometry’’ or ‘‘tissomics’’) (17,18), as well as to
analyze tissues that still reside in patients.
To address the significant challenges of in vivo micros-
copy and analysis of thick tissues, we have developed
a method that both reduces the effects of nonspecific sources
of contrast and provides a quantitative map of the binding
affinity of targeted molecular probes for their intended
biomarker. The technique we have developed utilizes
a two-color optical-sectioning microscope for simultaneous
imaging of a targeted imaging probe, at one wavelength,
with an appropriate negative control at the second wave-
length. By imaging a calibrated ratio of the signals from
both of these channels, we demonstrate accurate quantifica-Biophysical Journal 96(6) 2405–2414tion of biomarker expression and effective suppression of
nonspecific signals and background. This technique may
be generalized to a variety of molecular targeting mecha-
nisms, as well as a variety of scanning 3D optical sectioning
technologies, such as confocal microscopy and two-photon
microscopy. The method is demonstrated here using the
well-characterized HER2/neu (erbB2) monoclonal antibody
(aka Herceptin) as the molecular targeting moiety. This anti-
body targets a receptor tyrosine kinase that is overexpressed
in ~20–30% of human breast cancers. A nonspecific mono-
clonal antibody of the same isotype as the HER2/neu
(erbB2) antibody was used in a manner similar to its use in
flow cytometry as a control for nonspecific staining. To
obtain 3D microscopic data sets in this study, we used
a dual-axis confocal microscope designed by our group for
deep tissue imaging. To our knowledge, this is the first
demonstration of a two-color ratiometric technique to quan-
tify the level of specific binding of an exogenous fluorophore,
and to reduce the effects of nonspecific probe accumulation,
for improved detection of a molecular biomarker with
in vivo and ex vivo 3D microscopy of thick tissues.
METHODS
Cells and cell culture
Three breast cancer cell lines were used for quantitative ratiometric micros-
copy, as well as for flow cytometry validations. The SKBR3 cell line
(purchased from ATCC, Manassas, VA) was used as a strong positive
control for HER2/neu expression. In addition, MDA-MB-468 breast cancer
cells, transfected to express a weaker and variable level of HER2/neu, were
used for quantitative imaging (MDA-HER2) (19). A mock-transfected
version of the same cell line (MDA-NEO) was used as a negative control.
SKBR3 cells were grown in McCoy’s 5A medium supplemented with
10% fetal bovine serum and 1% penicillin/streptomycin at 37C in a 5%
CO2 incubator. MDA-HER2 and MDA-NEO cells were grown in Dulbec-
co’s modified Eagle’s medium supplemented with 5% fetal bovine serum
and 1% penicillin/streptomycin. At 75% confluence, the medium was aspi-
rated and the cells were detached with 1.5 mL 0.05% trypsin-EDTA. After
neutralization, the cells were pelleted at 300  g for 5 min. The pellet was
resuspended in 100 mL PBS per 1  106 cells.
Antibodies and ﬂuorescence labeling
An anti-HER2/neu monoclonal antibody (mAb), without BSA and Azide,
was obtained from Thermo Scientific (Waltham, MA, catalog No. MS-
229-PABX). This mAb (clone 9G6.10) was labeled with LI-COR (Lincoln,
NE) IRDye 800CW N-hydroxysuccinimide ester according to manufac-
turer’s recommendations that were provided with a microscale protein
labeling kit from LI-COR (928-38044). In summary, 20 mg of IRDye
800CW N-Hydroxysuccinimide ester was reacted for 2 h with 100 mg
of mAb in a 115-mL volume of 1 phosphate buffered saline (PBS)
(pH 8.5). A Pierce Zeba Desalting Spin column (Rockford, IL) was used
for purification. The final yield was ~90% with an average labeling ratio
of ~six dye molecules per antibody molecule.
An isotype-matched control mAb (Mouse IgG1), labeled with Alexa Fluor
647, was obtained from eBioscience (51-4714) (San Diego, CA). The
average dye labeling ratio of this product (lot No. E023666) was reported
by the manufacturer to be ~six dye molecules per antibody molecule.
For ratiometric imaging, cells were dual labeled with a 1:1 mixture of the
Licor-HER2 mAb (785-nm excitation) and the AF647-isotype control mAb
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FIGURE 1 Imaging setup. (A) The two-color DACM
with fluorescence excitation at 662 nm and 785 nm. (B)
Cultured cells and tissue samples are placed on the hemi-
spherical DACM sample holder and imaged in three
dimensions. (C) HER2-targeted antibodies and isotype-
control antibodies are labeled with different fluorophores
and mixed 1:1 for the dual labeling of cells and tissue
samples.(662-nm excitation). 1  106 cells were reacted with 2 mg of each of the
labeled antibodies in a 20 mL volume for 1 h. The cells were rinsed in
1 mL of PBS, spun down at 300  g for 5 min, and then resuspended in
100 mL PBS.
For flow cytometric analyses, 106 cells were reacted with 2 mg of either
the Licor-HER2 mAb or the AF647-isotype control mAb (662-nm excita-
tion). To compare antibody binding affinities accurately using a single emis-
sion/detection channel in the flow cytometer, a secondary anti-isotype
fluorescent antibody (2 mg; ab6785, Abcam, Cambridge, MA) was used to
identically label both of the primary antibodies (anti-HER2 and isotype
control). The secondary antibody, excited at 488 nm, was a FITC-labeled
Goat polyclonal to Mouse IgG antibody. Flow cytometry was performed
on a Becton Dickinson FACSCalibur (Franklin Lakes, NJ) and data
analyzed with FlowJo software (Ashland, OR).
Matrigel suspensions
For 3D imaging, HER2-positive cells were suspended in BD Matrigel Base-
ment Membrane Matrix. SKBR3 cells (1 103) were dual labeled with 2 mg
of each of the labeled antibodies in a 20-mL volume for 1 h. The cells were
then rinsed in 1 mL of PBS, spun down at 300  g for 5 min, and resus-
pended in 100 mL of Matrigel at 4C. The Matrigel matrix was then allowed
to warm up to 25C, where it quickly gelatinized.
To simulate a nonspecific background, a 1:1 mixture of the labeled
antibodies was introduced into the Matrigel matrix before introducing the
labeled cells. Specifically, 1 mg of both the Licor-HER2 mAb and the
AF647-isotype control mAb were added into 100 mL of Matrigel matrix.
1  106 labeled cells were then suspended into this matrix.
Frozen human breast cancer specimens
Snap-frozen, breast cancer tumor specimens, along with corresponding
normal breast tissue specimens from the same patient, were obtained from
the Stanford Tissue Bank. These tissues were embedded in optimal cutting
temperature (OCT) compound. HER2/neu expression levels were confirmed
by standard fluorescence in situ hybridization methods by the pthology
department at Stanford. Breast tumors with clinically elevated HER2 levels,
as indicated by fluorescence in situ hybridization analysis, as well as HER2-negative breast tumors, were imaged with 3D ratiometric microscopy. For
3D microscopy, a small (2  2  2 mm) cube of tissue was cut out of the
frozen specimen, taking care to remove the tissue from the OCT frozen
tissue matrix. As the tissue thawed out on a glass slide, a drop (2–3 mL)
of the 1:1 mixture of labeled antibodies (500 nM concentration of each fluo-
rescent antibody) was applied to the tissue and allowed to soak into the tissue
for 1 min. Dimethyl sulfoxide was added to the antibody solution to 5% final
concentration to facilitate penetration into the thick tissue specimen. After
the tissue was soaked in the antibody solution, it was irrigated with PBS
for 30 s to remove unbound probe. The tissue was then placed on the sample
holder of the dual-axis confocal microscope (DACM) and imaged.
Two-color DACM
A detailed description of the theory and imaging performance of a DACM for
deep-tissue optical sectioninghas been publishedpreviously (20,21).As illus-
trated in Fig. 1A, the two-color tabletop system incorporates two diode lasers,
at 662 nm and 785 nm,which are coupled into one singlemode fiber (Corning
HI780, Corning, NY). To increase the signal collection efficiency, a slightly
multimode fiber (SMF28), with a core diameter of 8.3 mm, is used as the
collection fiber for our DACM at the expense of a slight degradation in the
normally diffraction-limited performance, resulting in a spatial resolution
of 5-mm transverse and 7-mm axial (full width at half-maximum). The
collected light is collimated in free space and sent through a dichroic beam
splitter (Semrock, Rochester, NY, FF740-Di01-25 36) and the appropriate
filters (Semrock SP01-785RU-25 and LP02-664RU-25 for the AF647
channel; Semrock LP02-785RU-25 for the IRDye 800CW channel) to
separate the two fluorescent signals originating from each fluorophore into
two separate multimode fibers (50-mm core). Two fiber-coupled Hamamatsu
(Hamamatsu, Japan) photomultiplier tubes (H7422-50) are used for simulta-
neous detection of the two imaging channels, with each detector sending data
to a separate 8-bit frame grabber (Data Translation DT3152, Marlborough,
MA). The acquisition triggers, along with the horizontal- and vertical-sync
signals, are identical for both frame grabbers to insure image coregistration.
In addition, the achromatic DACM optics lead to a negligible offset in the
focal volumes for each wavelength.
In this study, the DACM provided vertical image sections, at a 2-Hz frame
rate, that were 600 mm wide by 320 mm deep (1000  420 pixels). For 3DBiophysical Journal 96(6) 2405–2414
2408 Liu et al.imaging, 300 vertical sections were acquired serially at 1-mm increments for
a total horizontal field of view of 600  300 mm (1000  300 pixels).
Quantitative ratiometric microscopy
and calibration
For quantitative ratiometric imaging of fluorescently labeled cells, cell
suspensions were applied to a microscope sample holder and allowed to
settle and form several cell layers, as illustrated in Fig. 1 B. For 3D imaging
of cells suspended in matrigel, the gelatinized cell suspensions were placed
on top of the microscope sample holder and imaged. Fig. 1 C depicts the
two-color dual-label contrast agent mixture used for this technique.
Before, or immediately after, the imaging of cell cultures or tissue speci-
mens, the two-color DACM was calibrated by imaging a diluted sample of
the 1:1 fluorescent antibody solution. The exact same laser intensity set points
and detector gain settingswere used to image the 1:1 antibodymixture aswere
used to image the labeled cell culture or tissue specimens. The ratio of the
average image intensity from each channel was measured and used as a cali-
bration factor to quantify the biological images. Additional details on calibra-
tion and image processing, alongwith a discussion of themathematicalmodel
and assumptions used for this technique, may be found in Appendix A.
Image processing
The theory behind our ratiometric technique is covered in greater detail in
Appendix A. For image processing, 3D image stacks (300 vertical sections)
were imported into an image-rendering software package (Amira 4.1, Carls-
bad, CA). Horizontal, en-face view projections (averaged in the vertical
z-direction), 5 pixels deep, were constructed in Amira to improve the
signal/noise ratio (SNR) of the images. Based on the sampling conditions
of our DACM, 5 pixels correspond to 3.8 mm in the vertical direction, which
is slightly greater than half the full width at half-maximum axial resolution
of the DACM (7 mm). Therefore, the Nyquist sampling criteria is nearly
satisfied with a 5-pixel projection, insuring minimal loss of information.
Horizontal projections from both image channels were imported into
MATLAB (TheMathWorks,Natick,MA),where a threshold routinewas first
applied to each image to ignore saturated pixels (intensity of 256) as well as
pixels within the noise floor (intensity of <5). A pixel-by-pixel ratio image
was then constructed from the two image channels (antibody-targeted and iso-
type control image). Finally, a predetermined calibration factor was applied to
the ratiometric image. Ratiometric images were then quantitatively displayed
using a false color look up table and rendered volumetrically in Amira 4.1.
RESULTS
Two-color DACM
For quantitative ratiometric imaging of fluorescently labeled
cells, cell suspensions were applied to the DACM sample
holder and allowed to settle and form several cell layers, as
illustrated in Fig. 1 B. Cells suspended in matrigel, as well
as human tissues, were also placed on top of the microscope
sample holder and volumetrically imaged. Fig. 1 C depicts
the two-color dual-label contrast agent mixture used for
this technique.
Quantitative imaging of cell culture
and comparison with ﬂow cytometry
For preliminary studies using HER2-positive breast cancer
cell lines, efficient antibody labeling and rinsing away of
unbound probe was expected. Therefore, the gain settingBiophysical Journal 96(6) 2405–2414for the HER2 channel of the DACM was intentionally low-
ered, with respect to the isotype-control channel, in anticipa-
tion of the large signal level from the HER2-antibody
channel. A calibration factor of 0.118 was measured, accord-
ing to the protocol described in the Methods section, reflect-
ing the low gain setting of the HER2 channel. Due to the
limited, 8-bit- (256 level-) dynamic range of our frame grab-
bers, it was necessary to carefully adjust the gain setting in
all our experiments to insure adequate SNR in our ratiomet-
ric images. Future systems, optimized for this technique, will
utilize higher dynamic range frame grabbers (12–16 bits) for
improved SNR and will be less dependent upon initial gain
settings (see Appendix B).
Fig. 2 A is a quantitative image, of the ratio between the
amount of HER2 antibody versus isotype control, of a hori-
zontal projection (5 pixels deep, see Methods) of SKBR3
cells deposited on the DACM sample holder. Note that the
ratiometric image displays Cspecific/Cnonspecific  1, rather
than simply the concentration ratio between the targeted
probe (specific) versus the nonspecific control probe:
Cspecific/Cnonspecific. In the absence of specific binding,
Cspecific ¼ Cnonspecific and Cspecific/Cnonspecific ¼ 1. Therefore
displaying (Cspecific/Cnonspecific  1) in ratiometric images
allows for more effective image interpretation in which
zero specific binding is indicated as zero image intensity.
The image histogram in Fig. 2 B indicates that the distri-
bution in the ratio, between HER2 antibody versus isotype
control, peaks at ~50. Flow cytometric data obtained for
the exact same cells used for ratiometric imaging, are shown
in Fig. 2 C. The difference in the fluorescence intensity
peaks, between the anti-HER2-mAb-labeled cells, and the
isotype-control-labeled cells, is ~50-fold and in excellent
agreement with the quantitative imaging results. For flow
cytometry, as described in the Methods section, a FITC-
labeled goat anti-mouse IgG secondary antibody was used
to label both the HER2 and isotype-control primary anti-
bodies attached to the SKBR3 cell surfaces. Therefore, since
a single emission/detection channel was used for all flow
analyses, the fluorescence intensities shown in Fig. 2 C
directly correlate with the two antibody concentrations.
In addition to the SKBR3 cell line, which exhibits strong
and uniform HER2 expression, we also utilized the MDA-
HER2 cell line that exhibits a weaker and more variable
cell-surface expression level for HER2. Fig. 3 displays
imaging and flow cytometry results, for the MDA-HER2
cell line, that are analogous to those in Fig. 2 for the
SKBR3 cell line. Both the ratiometric image, as well as the
flow-cytometry histogram, indicates a nonuniform distribu-
tion in HER2 expression. However, the ratio between the
peak levels of HER2 antibody versus isotype control is
~20 for both sets of data. Note that the image histogram in
Fig. 4 B becomes noisier at the lowest ratios because of
the limited 8-bit dynamic range of the frame grabbers used
in these experiments, coupled with the gain settings chosen
for acquiring this set of data.
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FIGURE 2 Quantitative imaging of SKBR3 cells. (A) A
ratiometric image of a ~10-mm thick horizontal (en-face
view) projection of SKBR3 cells. Pixel intensities corre-
spond to the ratio in the concentration of targeted HER2
antibody versus isotype control antibody. (B) A histogram
of the pixel intensities in the ratiometric image reveals
a peak ratio of ~50. (C) Flow cytometry validations (see
Methods) indicate a ~50 greater binding affinity of the
anti-HER2 mAb versus the isotype control.As a control study of the specificity of our HER2 antibody,
HER2-negative cells (MDA-NEO) were also labeled with
our dual-antibody mixture. Ratiometric imaging and flow
cytometry studies both revealed negligible differences between
the anti-HER2 mAb and the isotype control (not shown).
3D cell suspensions in matrigel
To demonstrate the ability to perform our quantitative
imaging technique in three dimensions, as well as to investi-
gate the potential for reducing nonspecific background
signals, we suspended antibody-labeled SKBR3 cells in
matrigel. A 1:1 mixture of our targeted antibody (channel 1)and isotype control antibody (channel 2) was mixed into the
matrigel (see Methods) to simulate a nonspecific back-
ground. A volume rendering of the image from channel 1
alone (targeted antibody) is shown in Fig. 4 A. The strongly
stained SKBR3 cells are visible, but are obscured by the
presence of a nonspecific background within the Matrigel.
Fig. 4 B displays an analogous volume rendering, after
ratiometric image processing. In addition to providing
a quantitative 3D map of the ratio between the amount of
HER2 antibody versus isotype control, a significant reduc-
tion in the nonspecific background is evident, leading to
improved image interpretation.FIGURE 3 Quantitative imaging of MDA-HER2 cells.
(A) A ratiometric image of a ~10-mm thick horizontal
(en-face view) projection of MDA-HER2 cells. Pixel inten-
sities correspond to the ratio in the concentration of targeted
HER2 antibody versus isotype control antibody. (B) A
histogram of the pixel intensities in the ratiometric image
reveals a peak ratio of ~20. (C) Flow cytometry validations
(see Methods) indicate a nonuniform expression of HER2
that results in a peak concentration of anti-HER2 mAb
that is ~20 the concentration of the isotype control.Biophysical Journal 96(6) 2405–2414
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As a final demonstration of our ratiometric technique, we
obtained snap-frozen specimens of HER2-positive and HER2-
negative breast cancers, along with normal breast tissue
samples from the corresponding patients. The tissues were
stained with our dual-antibody mixture (see Methods) and
rinsed in PBS before imaging. Fig. 5, A and B, show results
from a normal breast tissue sample, Fig. 5, C and D, are
images from a HER2-negative breast tumor, and Fig. 5, E
and F, are images from a HER2-positive breast tumor.
Fig. 5 A is a volume rendering of image channel 1 (targeted
antibody alone), indicating that a significant amount of
antibody has accumulated within the normal breast tissue
sample. However, once ratiometric image processing is per-
formed (Fig. 5 B), it is evident that the antibody accumulation
is largely nonspecific. Fig. 5C is a volume rendering of image
channel 1 for a breast tumor specimen. Ratiometric image pro-
cessing, shown in Fig. 5 D, helps to remove much of the
nonspecific background and reveals a low expression level
for HER2/neu. Fig. 5 E is a volume rendering, of image
channel 1, for a breast tumor specimen. Ratiometric image
processing, shown in Fig. 5 F, helps to remove much of the
nonspecific background and quantitatively confirms an
elevated HER2/neu expression level.
A B
FIGURE 4 3D quantitative micros-
copy of suspended cells. (A) A volume
rendering of channel 1 (HER2-targeted
mAb only), revealing a significant
amount of nonspecific background
signal (see Methods) obscuring the cells.
(B) A volume rendering after ratiometric
image processing, demonstrating
a significant reduction in nonspecific
background as well as a quantitative
map of the ratio between anti-HER2
mAb versus isotype control.
FIGURE 5 3D quantitative micros-
copy of human breast cancer and normal
samples. (A) Normal breast tissue:
a volume rendering of channel 1 (tar-
geted antibody probe), revealing signifi-
cant probe accumulation. (B) Normal
breast tissue (same volume as A):
a volume rendering, after ratiometric
image processing, which reveals
minimal signal that is molecularly
specific to the HER2/neu receptor. (C)
HER2-negative breast cancer: a volume
rendering of channel 1 (targeted anti-
body probe), revealing significant probe
accumulation. (D) HER2-negative
breast cancer (same volume as C):
a volume rendering, after ratiometric
image processing, demonstrating
removal of nonspecific background.
The ratiometric image indicates low
levels of HER2/neu expression. (E)
HER2-positive breast cancer: a volume
rendering of channel 1 (targeted anti-
body probe). (F) HER2-positive breast
cancer (same volume as E): a volume
rendering, after ratiometric image
processing, demonstrating a significant
reduction in nonspecific background as
well as a quantitative map of the ratio
between anti-HER2 mAb probe versus
isotypecontrol probe.ElevatedHER2/neu
expression is confirmed and quantified.Biophysical Journal 96(6) 2405–2414
Quantifying Cellular Biomarkers in 3D 2411FIGURE 6 Ratiometric optical sections, with line profiles. Line profile data are shown for the row of pixels indicated on the ratiometric optical sections. The
optical sections shown are 25 mm beneath the tissue surface and are taken from the same volumetric data set shown in Fig. 5. Line profiles are shown for both
raw imaging channels (channel 1, targeted antibody and channel 2, isotype control) as well as the calibrated ratiometric image. Note that the images display
(Cspecific/Cnonspecific  1) whereas the ratiometric line profiles display Cspecific/Cnonspecific. Column A (left) shows data from normal breast tissue. Column B
(center) shows data from a HER2-negative breast tumor. Column C (right) shows data from a HER2-positive breast tumor. See text for details.In Fig. 6, individual ratiometric image sections, from the
volumetric data shown in Fig. 5, are shown for normal breast
tissue, HER2-negative breast cancer, and HER2-positive
breast cancer. These horizontal (en-face) optical sections
are all located 25 mm beneath the tissue surface. Line profile
data are shown for the row of pixels indicated by a horizontal
line in the images. The first row of plots beneath the images
displays line profile data from both raw image channels.
Channel 1 is the fluorescence signal from the HER2-specific
probe whereas channel 2 is the signal from the nonspecific
isotype control probe. The plots at the bottom row represent
line profiles of the calibrated ratiometric data. Note that the
ratiometric images display Cspecific/Cnonspecific  1, whereas
the ratiometric line profiles display Cspecific/Cnonspecific. As
mentioned previously, in the absence of specific binding,
Cspecific ¼ Cnonspecific and Cspecific/Cnonspecific ¼ 1. Therefore
displaying Cspecific/Cnonspecific  1 in the ratiometric images
allows for more effective image interpretation in which
zero specific binding is indicated as zero image intensity.
From the line profiles shown in Fig. 6, the two major
advantages of our ratiometric imaging scheme are apparent.
First, it is possible to reduce the ambiguity in image interpre-tation due to nonspecific sources of contrast. For example, in
column A of Fig. 6, the channel 1 line profile for the normal
breast tissue optical section shows a large dip in intensity at
around pixel number 110, and also shows a drop in intensity
above pixel number 600. Since channel 2 exhibits an analo-
gous profile, the resulting ratiometric line profile reveals that
these intensity changes are not due to specific binding of the
anti-HER2 imaging probe. In addition to removing ambig-
uous nonspecific sources of differential contrast, the second
benefit of our technique is that it is quantitative. For example,
in column B of Fig. 6, channel 1 shows a fairly uniform stain-
ing intensity across the line profile (with the exception of
a dip at around pixel 100). In the absence of a calibrated
control, this signal could be interpreted either as a uniformly
high level of specific probe accumulation, or as a uniform
nonspecific accumulation of the imaging probe. By perform-
ing calibrated ratiometric microscopy, the intensity of the
probe may be quantified with respect to a nonspecific
control. In the case of the HER2-negative breast tumor
imaged in column B, the quantitative results indicate
a very low level of HER2-specific probe accumulation. Simi-
larly, the ratiometric line profile in column C of Fig. 6 clearlyBiophysical Journal 96(6) 2405–2414
2412 Liu et al.reveals and quantifies the level of specific probe accumula-
tion relative to a nonspecific control.
Nonuniformity and uncertainty
One nonideal feature of the DACM used in this study is that
signal intensities drop off slightly at the edges of the field of
view, owing to scanning-induced optical aberrations. Ratio-
metry helps to counteract nonuniformities such as this
because even though the raw signals intensities are falling
off in both channels, their ratio is insensitive to such
common-mode losses and remains accurate. SNR does
degrade as the raw signal levels drop. This is accounted
for in the image-processing algorithm by removing all pixels
that are below a certain signal threshold (<5 out of 256 gray-
scales). Therefore, at the edges of the ratiometric images,
more pixels are given a value of zero (black on the color
map). Nevertheless, the ratiometric image histograms main-
tain an accurate shape because they neglect zero-valued
pixels, although the distributions become noisier as the raw
signal levels drop.
An analysis of the effects of noise sources, such as digiti-
zation noise (bit noise), on this quantitative method is
performed in Appendix B. For a frame grabber with an 8-bit
dynamic range, as used in this study, digitization noise alone
accounts for at least a 1% uncertainty in the ratiometric
result. This is for a best-case scenario in which the system
gain settings are optimally set such that the raw signal levels
fall at the center of the dynamic range of the frame grabbers.
In practice, when imaging a heterogeneous sample with any
contrasting features, the uncertainty due to digitization noise
is much worse (see Appendix B). For a 12-bit frame grabber,
which is preferred for future studies, the digitization-induced
uncertainty is more than an order of magnitude lower. As
mentioned previously, our image processing algorithm
removes all pixels with a signal intensity of <5 out of 256
pixels. At such low signal levels, the uncertainty due to digi-
tization noise is at least 20% and is unacceptable for reliable
ratiometry. Additional noise sources, such as laser, detector,
and shot noise (which propagate according to Eq. B.3 in
Appendix B) should be carefully considered when utilizing
this technique to insure robust quantification of probe
concentrations.
DISCUSSION
We have developed a ratiometric image-processing method
to quantify cellular biomarker expression and to reduce the
confounding effects of nonspecific probe accumulation for
microscopic analyses of thick or intact tissues. This tech-
nique is designed to address recent challenges in in vivo
3D microscopy, in which topical application and rinse-
removal of imaging probes is nonuniform and inefficient,
leading to misleading signals that are not molecularly
specific. To demonstrate this two-color ratiometric tech-Biophysical Journal 96(6) 2405–2414nique, a monoclonal antibody is used to target the HER2/
neu tyrosine kinase receptor that is often overexpressed in
breast tumors. However, this technique is not limited to anti-
body-based imaging probes and should have utility for other
targeting moieties such as peptides. With peptide imaging
probes, a suitable negative-control peptide, such as a scram-
bled peptide, would need to be used with similar nonspecific
binding characteristics as compared to the targeting peptide.
These smaller molecular probes would diffuse into and out of
tissues more readily and offer advantages for tissue staining
and in vivo imaging.
In this study, we have presented data using HER2-positive
cell cultures that demonstrate the accuracy of our calibrated
image-processing technique to quantify the ratio between
molecularly targeted versus nonspecific probe accumulation.
Our imaging results, of labeled breast cancer cells, compare
favorably with quantitative flow cytometry analysis. We
have also suspended labeled cells in Matrigel, and have
simulated a nonspecific background within the Matrigel, to
demonstrate the ability of our technique to quantify
biomarker expression levels in three dimensions and to
greatly reduce the effects of a nonspecific background.
Finally, we have demonstrated this technique on thick
samples of excised human breast cancer and normal breast
tissue. By performing calibrated ratiometric image process-
ing, we demonstrate the ability to quantify specific probe
binding and to reduce ambiguity due to nonspecific probe
accumulation. This quantitative imaging technique improves
the ability to distinguish normal tissue and HER2-negative
tumors from HER2-positive tumors in thick tissue 3D
microscopy, in which the staining and rinsing away of
contrast agents is inefficient. As such, these data indicate
that microscopic analyses of entire tissue biopsies could be
performed rapidly and in close proximity to the patient,
and reveal both the presence and extent of biomarker expres-
sion throughout the entire sample. This would be useful for
diagnosis and guiding therapy, could be easily automated,
and would remove sampling errors that occur in analyzing
selected sections of a tissue.
A number of major assumptions, detailed in Appendix A,
must be satisfied to maintain the accuracy of our ratiometric
technique. Although we have presented data demonstrating
the feasibility of this technique, certain improvements could
be made to optimize future results. As mentioned in the
Results section, frame grabbers with a higher dynamic range
(at least 12 bits) are needed to improve the SNR of the ratio-
metric images, and to reduce the sensitivity of this technique
to initial laser and detector gain settings. In these studies, two
near-infrared cyanine dyes were used: Alexa Fluor 647 and
LI-COR IRDye 800CW. Although these dyes are structur-
ally similar, it is important to carefully study and optimize
our choice of fluorescent dyes in the future to insure similar
behavior in tissues. The structure, polarity, and steric config-
uration of the dyes should be as similar as possible to mini-
mize dye-associated differences between the targeted and
Quantifying Cellular Biomarkers in 3D 2413negative-control imaging probes. This similarity in the dyes
is particularly important if small-molecule targeting agents
such as peptides are to be used, since the dye molecules
(~1 kDa) will play a much larger role in the binding dynamics
and diffusion of such small-molecule probes (~1–10 kDa), as
compared to large antibodies (150 kDa). Finally, whether
small-molecule or antibody probes are utilized, the ability
to distinguish between specific and nonspecific binding
depends upon the accuracy of the negative-control to mimic
the nonspecific effects of the targeted probe. As with flow
cytometry, care must be taken to develop appropriate posi-
tive and negative probes for this purpose, especially as novel
small-molecule reagents are utilized.
The technique described in this article was developed
specifically to address challenges in image interpretation
during in vivo and ex vivo 3D microscopy of thick intact
tissues with topically applied molecular contrast agents. By
attenuating the effects of nonspecific background signals
caused by ineffective probe application and rinsing, and by
providing quantification of specific probe binding relative
to nonspecific binding, this ratiometric method is an impor-
tant step toward the larger goal of in vivo optical biopsy and
accurate real-time histopathology of intact tissue samples.
The ability to quantitatively visualize molecular biomarkers
in unfixed and intact tissues, through the use of advanced
microscopy techniques coupled with digital image process-
ing, represents what we believe is an exciting new approach
to disease detection and pathology with the potential to
accelerate the analysis, increase the accuracy, and reduce
the cost associated with disease diagnosis.
APPENDIX A: MODEL AND ASSUMPTIONS
Voxel intensities, Si, for each wavelength channel, i, may be expressed as
Si ¼ Gi , ni , ci , Ii , si ,ci; (A1)
where:
Gi ¼ electronic gain and system constants (optical efficiency, detector
quantum yield, etc.).
ni ¼ average number of dye molecules per antibody.
ci ¼ concentration of antibody (or generic targeted contrast agent).
Ii ¼ laser intensity at voxel volume.
si ¼ absorption cross-section of dye.
ci ¼ fluorescence yield of dye.
A number of assumptions must be true to maintain the accuracy of the
calibrated ratiometric image-processing technique used in this study:
1. The ratio of the laser intensities is constant (i.e., I1I2 is constant) throughout
the imaged volume. With achromatic optics, both wavelengths travel
identical paths within the tissue. If we assume that absorption is negli-
gible compared to scattering losses (true for the near-infrared (NIR)
wavelengths used), then the ratio in the laser intensities will be constant
with imaging depth if the scattering coefficient is the same for both wave-
lengths. Although the scattering coefficient does vary as a function of
wavelength, we are assuming that this difference is negligible over the
few hundred microns of depth that we are imaging. Note: if both fluoro-
phores were excited with one laser source, as could be possible if
quantum dots were used, then I1I2 ¼ 1.2. There is negligible crosstalk between channels, due to poor filtering,
FRET effects, etc.
3. There is negligible autofluorescence (we use NIR wavelengths to avoid
autofluorescence).
4. There is negligible variation in absorption cross section and fluorescence
yield of the dye in the sample.
5. The dye labeling is dense enough that ensemble averages are valid for
each voxel (i.e., the average number of dye molecules per antibody, ni,
does not vary for each voxel).
Assume that we have a two-color multispectral system, with fluorophores
1 and 2. If the optical alignment and gain settings of the DACM are fixed,
and if assumptions 1–5 above are satisfied, then we can say that for each
voxel, k1k2 is a constant, where ki ¼ Gi,ni,Ii,si,ci.Therefore,
S1
S2
¼ G1 , n1 , c1 , I1 , s1 ,c1










The calibration constant, k1k2, is measured by imaging a 1:1 mixture of dye-
labeled antibody, where c1c2 ¼ 1. Once the calibration factor is measured,
ratiometric image processing (see Methods) is used to quantify the ratio of













APPENDIX B: UNCERTAINTY ANALYSIS
For each voxel in channel i, there is an average value Si with an associated
uncertainty dSi such that
Si ¼ Si  dSi: (B1)
The ratio, R, defined in (A.3), may also be expressed as
R ¼ R  dR: (B2)















To analyze the effects of digitization noise, we define n¼ bit depth where
the number of digitization levels (i.e., grayscales) is 2n. With optimized gain
settings, the average signal level is at approximately half the full dynamic
range: 1/2(2n) ¼ 2n1. The fractional uncertainty due to digitization noise




















Thus, for an 8-bit frame grabber, dR
R




Assume that we are imaging a tumor margin, or a specific tissue compo-
nent, using a molecular imaging probe that offers a contrast ratio of r. In the
best case scenario, with optimized gain settings, the negative-control
channel (channel 2) as well as the positive signal levels in channel 1 are
detected by an n-bit frame grabber at a level of approximately 2n1. The
negative signal levels in channel 1 are recorded at approximately 2n1/r.
The fractional uncertainties due to digitization are 1/2n1 and r/2n1,Biophysical Journal 96(6) 2405–2414
2414 Liu et al.respectively. The uncertainty in the resulting ratiometric image is limited by


















If the contrast ratio is r ¼ 5, then for an 8-bit digitizer, dR
R
R4%, whereas
for a 12-bit digitizer, dR
R
R0:25%.
Other noise sources, such as shot noise, detector noise, and electronic
noise, also propagate according to Eq. B3 and will contribute to the reli-
ability of R. Ideally, fluorescence signals should be detected with SNR
comparable to or better than the SNR due to digitization noise, as described
above.
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